Insider trades
Songjiang Ma, President of Gyre Therapeutics GYRE, has filed 0 purchases and 86 sales on the open market. The latest trade was on 25/05/28.
Songjiang Ma
President
- Company
- Gyre Therapeutics GYRE
- First filing
- 23/11/22
- Trades
- 88 trades
- Buys / sales
- 0 / 86
- 12-month net buying
- No record
- Last trade
- 25/05/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
GYRE | Open-market sale10b5-1 plan | 25/05/27–25/05/28 | 25/05/29 | 2,558 sh2 trades | $10.23avg. | $26,179.06 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/05/22–25/05/23 | 25/05/27 | 2,182 sh2 trades | $10.91avg. | $23,803.68 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/05/20–25/05/21 | 25/05/22 | 4,000 sh2 trades | $11.04avg. | $44,160 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/05/16–25/05/19 | 25/05/20 | 4,000 sh2 trades | $11.21avg. | $44,840 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/05/14–25/05/15 | 25/05/16 | 2,020 sh2 trades | $10.69avg. | $21,586 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/05/12–25/05/13 | 25/05/14 | 4,000 sh2 trades | $10.97avg. | $43,860 | −0.1% |
| Open-market sale10b5-1 plan | 25/03/21 | 25/03/25 | 174 sh | $10.00 | $1,740 | −0.0% | |
GYRE | Open-market sale10b5-1 plan | 25/03/19–25/03/20 | 25/03/21 | 4,000 sh2 trades | $10.11avg. | $40,440 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/03/17–25/03/18 | 25/03/19 | 2,242 sh2 trades | $11.89avg. | $26,658.08 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/03/13–25/03/14 | 25/03/17 | 4,000 sh2 trades | $12.06avg. | $48,220 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/03/11–25/03/12 | 25/03/13 | 4,000 sh2 trades | $11.57avg. | $46,280 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/03/07–25/03/10 | 25/03/11 | 4,000 sh4 trades | $10.19avg. | $40,776.11 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/03/05–25/03/06 | 25/03/07 | 4,000 sh2 trades | $10.89avg. | $43,560 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/03/03–25/03/04 | 25/03/05 | 4,000 sh2 trades | $11.05avg. | $44,180 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/02/27–25/02/28 | 25/03/03 | 4,000 sh2 trades | $11.37avg. | $45,480 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/02/25–25/02/26 | 25/02/27 | 4,000 sh2 trades | $11.50avg. | $46,000 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/02/21–25/02/24 | 25/02/25 | 4,000 sh4 trades | $11.30avg. | $45,190.36 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/02/19–25/02/20 | 25/02/21 | 4,000 sh2 trades | $12.35avg. | $49,380 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/02/14–25/02/18 | 25/02/19 | 4,000 sh2 trades | $12.22avg. | $48,860 | −0.1% |
GYRE | Open-market sale10b5-1 plan | 25/02/12–25/02/13 | 25/02/14 | 4,000 sh2 trades | $11.59avg. | $46,360 | −0.1% |